Aprea Therapeutics, Inc. (APRE)

Aprea Therapeutics Revenue

Aprea Therapeutics had revenue of $123.30K in the twelve months ending March 31, 2026, down -90.40% year-over-year. In the year 2025, Aprea Therapeutics had annual revenue of $285.76K, down -80.98%.

• Revenue (ttm): $123.30K
• Revenue Growth: -90.40%
• P/S Ratio: 73.24
• Revenue / Employee: $15,412
• Employees: 8
• Market Cap: 9.03M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	285.76K	-1.22M	-80.98%
Dec 31, 2024	1.50M	919.35K	157.63%
Dec 31, 2023	583.23K	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 16, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 16, 2026

Data Sources Report a data error